The impact of station 4L lymph node dissection on short-term and long-term outcomes in non-small cell lung cancer

医学 解剖(医学) 淋巴结 倾向得分匹配 内科学 淋巴 肺癌 肿瘤科 阶段(地层学) 纵隔淋巴结 子群分析 逻辑回归 泌尿科 外科 癌症 置信区间 病理 转移 古生物学 生物
作者
Yang Wo,Hang Li,Yang Zhang,Yizhou Peng,Zhigang Wu,Pengcheng Liu,Yan Shang,Hong Hu,Yawei Zhang,Jiaqing Xiang,Yihua Sun
出处
期刊:Lung Cancer [Elsevier BV]
卷期号:170: 141-147 被引量:10
标识
DOI:10.1016/j.lungcan.2022.06.018
摘要

Objective The optimal extent of lymph node dissection (LND) remains controversial. We aimed to investigate whether the addition of station 4L lymph node dissection (S4L-LND) was beneficial for non-small cell lung cancer (NSCLC). Methods Data on 1040 left-sided NSCLC patients undergoing rigorous systematic LND were retrospectively reviewed. Multivariate logistic regression analysis determined risk factors of station 4L (S4L) nodal involvement to facilitate risk stratified analysis of the significance of S4L-LND. Propensity score matching (PSM) was conducted to reduce disparities of baseline characteristics between S4L-LND group and no-S4L-LND group. Recurrence-free survival (RFS), overall survival (OS), and postoperative complications were compared. Results S4L-LND was performed in 586 (56.3%) patients. The S4L nodal involvement rate was 15.5% (91/586). Aortopulmonary zone nodes involvement (P < 0.001), N1 nodes involvement (P < 0.001), and advanced T stage (P = 0.015) were independent risk factors of S4L nodal involvement. Patients with ≥ 2 risk factors of S4L nodal involvement were classified as high risk group, and the others were classified as low risk group. Among patients with negative aortopulmonary zone nodes and inferior mediastinal nodes (n = 425), only 28 (6.6%) patients had S4L involvement. After PSM, a total of 416 pairs were well matched. There was no significant survival difference between S4L-LND group and no-S4L-LND group (OS, P = 0.247; RFS, P = 0.569). When stratified by risk subgroup, S4L-LND group did not demonstrate superior survival than no-S4L-LND group in the high risk group (OS, P = 0.273; RFS, P = 0.754) or the low risk group (OS, P = 0.558; RFS, P = 0.319). S4L-LND group demonstrated significantly greater risk of postoperative complications than no-S4L-LND group (9.6% vs. 5.8%; P = 0.037). Conclusions S4L involvement was not rare and usually occurred with multiple nodal stations involvement. Routine dissection of aortopulmonary zone and inferior mediastinal nodes was sufficient to ensure staging accuracy. The addition of S4L-LND did not improve survival, but might increase the risk of postoperative complications.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
yhhhhhh完成签到,获得积分10
3秒前
直率无春完成签到,获得积分10
3秒前
SciGPT应助beimi采纳,获得30
4秒前
5秒前
Zoe完成签到,获得积分10
8秒前
8秒前
9秒前
XZY完成签到,获得积分10
10秒前
sunsaint完成签到,获得积分10
11秒前
f_2097353发布了新的文献求助10
12秒前
HoaryZ完成签到,获得积分10
13秒前
captain601发布了新的文献求助10
13秒前
sdjtxdy发布了新的文献求助10
15秒前
科研通AI6.2应助小巧晓夏采纳,获得10
15秒前
Scorpia112应助吴雨茜采纳,获得10
16秒前
f_2097353完成签到,获得积分10
16秒前
17秒前
老实的乐儿完成签到 ,获得积分10
18秒前
耗子完成签到,获得积分10
19秒前
沈冷完成签到,获得积分10
19秒前
李健应助Ronin采纳,获得10
20秒前
苯环完成签到,获得积分10
21秒前
毛毛余完成签到 ,获得积分10
23秒前
23秒前
CipherSage应助萨达采纳,获得10
24秒前
乔伊应助占曼荷采纳,获得10
25秒前
上官若男应助来福采纳,获得10
25秒前
chen完成签到,获得积分10
26秒前
26秒前
Ava应助michaelzy1127采纳,获得10
26秒前
严姸发布了新的文献求助10
28秒前
律lv发布了新的文献求助10
31秒前
32秒前
三三完成签到 ,获得积分10
32秒前
天际小山完成签到,获得积分10
33秒前
chang完成签到,获得积分10
34秒前
35秒前
35秒前
35秒前
37秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Developing Genetic Editing Tools for Lysobacter 2000
Моделирование процессов самоорганизации в кристаллообразующих системах 1000
History of U.S. Space Surveillance and Satellite Cataloging 1000
Adhesion Science: Principles & Practice 800
Signals, Systems, and Signal Processing 610
Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective, Second Edition 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6524922
求助须知:如何正确求助?哪些是违规求助? 8318242
关于积分的说明 17801447
捐赠科研通 5626734
什么是DOI,文献DOI怎么找? 2928958
邀请新用户注册赠送积分活动 1905628
关于科研通互助平台的介绍 1765508